Matches in Nanopublications for { ?s ?p "[To elucidate the underlying mechanism, we assessed RB1 promoter hypermethylation using methylation-specific polymerase chain reaction and RB1 expression by immunohistochemistry in 35 primary (de novo) glioblastomas and in 21 secondary glioblastomas that had progressed from low-grade diffuse astrocytoma (WHO Grade II) or anaplastic astrocytoma (WHO Grade III).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP883805.RAXlAFxJ5weZ0HZIy8tf-mSOKNnOcfN8pYNgwgEu5z4ZI130_assertion description "[To elucidate the underlying mechanism, we assessed RB1 promoter hypermethylation using methylation-specific polymerase chain reaction and RB1 expression by immunohistochemistry in 35 primary (de novo) glioblastomas and in 21 secondary glioblastomas that had progressed from low-grade diffuse astrocytoma (WHO Grade II) or anaplastic astrocytoma (WHO Grade III).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP883805.RAXlAFxJ5weZ0HZIy8tf-mSOKNnOcfN8pYNgwgEu5z4ZI130_provenance.
- NP427299.RAKU6dQxsvnOzw37WhGZmaI_9JtatJGYpl-4nxntILh7E130_assertion description "[To elucidate the underlying mechanism, we assessed RB1 promoter hypermethylation using methylation-specific polymerase chain reaction and RB1 expression by immunohistochemistry in 35 primary (de novo) glioblastomas and in 21 secondary glioblastomas that had progressed from low-grade diffuse astrocytoma (WHO Grade II) or anaplastic astrocytoma (WHO Grade III).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427299.RAKU6dQxsvnOzw37WhGZmaI_9JtatJGYpl-4nxntILh7E130_provenance.
- assertion description "[To elucidate the underlying mechanism, we assessed RB1 promoter hypermethylation using methylation-specific polymerase chain reaction and RB1 expression by immunohistochemistry in 35 primary (de novo) glioblastomas and in 21 secondary glioblastomas that had progressed from low-grade diffuse astrocytoma (WHO Grade II) or anaplastic astrocytoma (WHO Grade III).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP308315.RAComXZmikDfC-tjKWnrSbPgpMeX8BLhCgy6tGiTg-2Ps130_assertion description "[To elucidate the underlying mechanism, we assessed RB1 promoter hypermethylation using methylation-specific polymerase chain reaction and RB1 expression by immunohistochemistry in 35 primary (de novo) glioblastomas and in 21 secondary glioblastomas that had progressed from low-grade diffuse astrocytoma (WHO Grade II) or anaplastic astrocytoma (WHO Grade III).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP308315.RAComXZmikDfC-tjKWnrSbPgpMeX8BLhCgy6tGiTg-2Ps130_provenance.
- NP667106.RAvZ0K2869zZ4ZAsp9NGlCIdbRpCcC2fbTh85XeFpLzck130_assertion description "[To elucidate the underlying mechanism, we assessed RB1 promoter hypermethylation using methylation-specific polymerase chain reaction and RB1 expression by immunohistochemistry in 35 primary (de novo) glioblastomas and in 21 secondary glioblastomas that had progressed from low-grade diffuse astrocytoma (WHO Grade II) or anaplastic astrocytoma (WHO Grade III).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP667106.RAvZ0K2869zZ4ZAsp9NGlCIdbRpCcC2fbTh85XeFpLzck130_provenance.